Examination of the functions and mechanism of KCP in mediating paclitaxel resistance in cervical squamous carcinoma cells

Examination of the functions and mechanism of KCP in mediating paclitaxel resistance in cervical squamous carcinoma cells

ObjectiveTo evaluate the mechanism of Kielin/chordin-like protein (KCP) in the resistance of cervical cancer cells to paclitaxel.MethodA cervical squamous carcinoma cell line (SiHa) with KCP knockout was constructed and treated with paclitaxel. Key cell functions were assessed by colony formation as...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yue He, Jian-Qing Xu, Jing-Jing Zhang, Zhen-You Liu, Chen Ji, Yang Liu, Yun-Fan Wang, Ming Wang, Yu-Mei Wu, Yan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Oncology
Subjects:	Kielin/chordin-like protein paclitaxel resistance cervical squamous cell carcinoma mechanism functions
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1550032/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The combination of paclitaxel and ipatasertib affects the death, proliferation, and autophagy response of oral squamous cell carcinoma cells
by: CHE Di, et al.
Published: (2025-02-01)

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study
by: Xiaoyou Li, et al.
Published: (2025-04-01)

Hyperfractionated radiotherapy with concurrent weekly paclitaxel and carboplatin for locally advanced unresectable head and neck squamous cell carcinoma
by: Perumal S, et al.
Published: (2025-06-01)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01)

Case Report: Osteoclastic giant cell-rich cervical squamous cell carcinoma—the first reported case of a clinically silent early-detected keratinizing subtype with a detailed literature comparison
by: Lukasz Fulawka, et al.
Published: (2025-05-01)

Comparative acute toxicity of intravenous paclitaxel and sirolimus in rats
by: Jing Xie, et al.
Published: (2025-01-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
by: Marieke Schmidt, et al.
Published: (2024-12-01)

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel
by: Hilal Susam Şen, et al.
Published: (2020-10-01)

Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015–2023
by: Yiming Wang, et al.
Published: (2025-05-01)

Preparation of Glutathione-Responsive Paclitaxel Prodrug Based on Endogenous Molecule of L-Glutathione Oxidized for Cancer Therapy
by: Xiao Duan, et al.
Published: (2024-09-01)

Paclitaxel resistance in breast cancer: Current challenges and recent advanced therapeutic strategies
by: Heidi A. Abouzeid, et al.
Published: (2025-01-01)

Development and validation of a prognostic model for efferocytosis-associated genes in cervical squamous cell carcinoma
by: Lan-lan Ma, et al.
Published: (2025-07-01)

Predicting lymphovascular space invasion in early-stage cervical squamous cell carcinoma using heart rate variability
by: Junlong Fang, et al.
Published: (2025-07-01)

Squamous cell carcinoma antigen levels in women with cervical cancer and those without cervical cancer: a cross-sectional study among women of African descent
by: Maradona Isikhuemen, et al.
Published: (2025-07-01)

Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2023-02-01)

The mechanism of paclitaxel induced damage on placental trophoblast cells
by: Yang Yu, et al.
Published: (2024-10-01)

Spatial transcriptomics reveals unique metabolic profile and key oncogenic regulators of cervical squamous cell carcinoma
by: Limin Zhou, et al.
Published: (2024-12-01)

SQUAMOUS CELL CARCINOMA METASTASES TO THE CERVICAL LYMPH NODES WITHOUT A PRIMARY FOCUS BEING DETECTED
by: O. A. Saprina
Published: (2015-04-01)

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery
by: Siqi Wu, et al.
Published: (2025-06-01)

Emerging trends and global collaboration in Paclitaxel resistance research for breast cancer: a comprehensive bibliometric study
by: Yuxuan Meng, et al.
Published: (2025-08-01)

Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China
by: Luwei Wang, et al.
Published: (2025-07-01)

Endoscopic ultrasound-guided ethanol vs ethanol combined with paclitaxel for the ablation of pancreatic cystic lesions: a systematic review and meta-analysis
by: Cong Ding, et al.
Published: (2025-04-01)

Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis
by: Koren Miha, et al.
Published: (2025-04-01)

A novel isoquinoline mitophagy inducer ameliorates paclitaxel-induced peripheral neuropathy in Drosophila and mouse models
by: Sangwoo Im, et al.
Published: (2025-07-01)

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)

Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer
by: Zahra Tajik, et al.
Published: (2025-08-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Formulation and evaluation of cetuximab functionalized phospholipid modified nanocrystals of paclitaxel for non-small cell lung cancer therapy
by: Manish Kumar, et al.
Published: (2024-11-01)

Role of lncRNA TPRG1-AS1 in the development of cervical squamous cell carcinoma and its prognostic value
by: Yang Fan, et al.
Published: (2024-12-01)

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma
by: Shuhang Wang, et al.
Published: (2020-05-01)

Cervical intraepithelial neoplasia and cervical cytology in pregnancy
by: Ji-Young Kim, et al.
Published: (2024-11-01)

Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells
by: Stefania Scicchitano, et al.
Published: (2025-03-01)

Reestenosis de stents liberadores de paclitaxel frente a stents convencionales
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Evaluation of the Safety and Efficacy of N-acetylcysteine in the Prevention of Paclitaxel-induced Peripheral Neuropathy: A Randomized, Double-blind, and Placebo-controlled Trial
by: Sima Ramezaninejad, et al.
Published: (2025-01-01)

Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
by: Fei-Yu Wang, et al.
Published: (2025-03-01)

A CASE OF MULTIPLE PRIMARY CANCER: SYNCHRONOUS CERVICAL ADENOCARCINOMA AND SQUAMOUS CELL OVARIAN CARCINOMA
by: S. V. Molchanov, et al.
Published: (2016-04-01)